The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Ocado, Abcam

Tue, 20th Jun 2023 08:22

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p and placed the stock on 'negative catalyst watch' into first-half results.

JPM said: "We believe Ocado's online grocery activities will continue to face meaningful headwinds in the next months."

The bank, which rates Ocado at 'underweight', said the latest Kantar data suggest ongoing market share gains for offline discounters given the current macro backdrop/falling consumer budgets.

It also noted that higher, inflation-driven average selling prices are almost fully offset by lower basket sizes, while cost inflation - wages but also electricity, icing etc - is negatively impacting UK Retail's bottom line.

JPM said it sees downside to consensus FY23 estimates.

"With Ocado's UK Retail operations barely profitable in 2023, we see limited scope for Retail to act as the required showcase for the company's Solutions operation," it said.

It also said it's "becoming clearer" that the shift towards more customer fulfilment centres (CFCs) is likely to remain slow for supermarkets as in-store picking solutions seem currently to be the preferred choice to better monetise the established branch network and limit capex.

JPM said that despite Ocado's recent share price weakness - the shares are down 30% year-to-date and 44% in the last 12 months - the current share price levels still reflect an additional 54 CFCs to be announced.

"With (a lack of) new partnership announcements likely to remain the key share price driver from here, we see risk-reward still as unattractive versus other names in the EU Internet sector and remain UW."

RBC Capital Markets downgraded Abcam to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as it recommended investors take profit on bid anticipation.

It noted that the shares are up 40% in the last 10 days, and 65% in the quarter to date.

"It is unclear how advanced the 'strategic inquiries' are, and the valuation work in this report implies relatively little further upside on a transaction anyway," RBC said.

"We have always liked Abcam's fundamentals but see activist investor engagement and anticipation of a potential bid as likely to drive material volatility in the shares.

"While our $22 price target informs our downgrade to sector perform, we would take profits here."

More News
20 Apr 2020 10:02

Abcam warns on revenues as Covid-19 hits markets

(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.

Read more
20 Apr 2020 09:41

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

Read more
14 Apr 2020 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Apr 2020 18:07

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
10 Mar 2020 09:38

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

Read more
9 Mar 2020 15:48

Abcam 'uncertain' about coronavirus impact as China returns to work

(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.

Read more
9 Mar 2020 10:29

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

Read more
9 Mar 2020 09:55

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

Read more
4 Mar 2020 10:26

Abcam acquires Marker Gene Technologies

(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.

Read more
4 Mar 2020 10:13

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Read more
2 Mar 2020 15:56

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
30 Jan 2020 10:51

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Read more
28 Jan 2020 18:46

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.